4 Osteoporosis: pathogenesis and risk factors

Bailliere's Clinical Endocrinology and Metabolism

Volumn 2, Issue 1, 1988, Pages 87-101

  Stevenson, John C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM;

ADULT; AGE; AGED; BONE DENSITY; HUMAN; OSTEOPOROSIS; POSTMENOPAUSE; REVIEW; RISK FACTOR; SEX DIFFERENCE;

AGING; BONE AND BONES; BONE DEVELOPMENT; FEMALE; HUMAN; MALE; OSTEOPOROSIS; RISK FACTORS; SEX FACTORS;

EID: 0023893838     PISSN: 0950351X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-351X(88)80009-0     Document Type: Article

References (108)

1. Differential bone loss and effects of long-term oestrogen therapy according to time of introduction of therapy after oophorectomy
2. Osteoporosis and its relationship to oestrogen deficiency
3. The effect of long-term mestranol administration on calcium and phosphorus homeostasis in oophorectomised women
4. Long term effect of oestrogen replacement therapy on bone mass as measured by dual photon absorptiometry
5. Postmenopausal osteoporosis
6. Oestrogen receptors and human bone cells: an immunocytochemical study
7. Modified method of spinal computed tomography for trabecular bone mineral measurement
8. Precision and accuracy of bone mineral determination by direct photon absorptiometry
9. Precise measurement of vertebral mineral content using computed tomography
10. Decreased spinal mineral content in amenorrhoeic women
11. Effect of estrogens and phosphorus depletion on plasma calcitonin in the rat
12. Effect of parathyroid hormone and calcitonin on the cytoplasmic spreading of isolated osteoclasts
13. Distinction between alpha-fetoprotein and intracellular estrogen receptors: evidence against the presence of estradiol receptors in rat bone
14. Prevention of early postmenopausal bone loss; controlled 2-year study in 315 normal females
15. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy
16. Monoclonal antibodies against a component related to soluble estrogen receptor
17. Comparative skeletal mass and radial bone mineral content in black and white women
18. Osteoporosis of the slender smoker: vertebral compression fractures and loss of metacarpal cortex in relation to postmenopausal smoking and lack of obesity
19. Total and free estrogens and androgens in postmenopausal women with hip fractures
20. Influence of age and sex on plasma calcitonin in human beings
21. Oestrogens et calcitonine
22. Relation between bone mass and muscle weight
23. Evidence of estrogen receptors in human bone cells
24. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium
25. Prostaglandin production by calvariae from sham operated and oophorectomized rats: effects of 17B-estradiol in vivo
26. Deficit de calcitonina en la osteoporosis posmenopausica
27. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients
28. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis
29. Bone loss and aging
30. Quantitative bone mineral analysis using dual-energy computed tomography
31. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy
32. The treatment of osteoporosis with estrogens
33. Bone mineral: effects of oral contraceptives, pregnancy, and lactation
34. Effects of estradiol and progesterone on calcitonin secretion
35. A longitudinal study of falls in an elderly population: 1. Incidence and morbidity
36. The Low Incidence of Fracture of the Hip in the Negro
37. Direct measurement of osteolysis in man
38. 3: possible clues to the pathogenesis of postmenopausal osteoporosis
39. Menopausal changes in calcium balance performance
40. Menopausal changes in bone remodelling
41. Plasma calcitonin in normal man
42. Relative deficiency of plasma-calcitonin in normal women
43. Prospective trial of oestrogen and calcium in postmenopausal women
44. Axial and appendicular bone mineral density in patients with long-term deficiency or excess of calcitonin
45. Epidemiology of postmenopausal spinal and long bone fractures: a unifying approach to postmenopausal osteoporosis
46. Cigarette-smoking, serum estrogens and bone loss during hormone-replacement therapy early after menopause
47. On some late effects of bilateral oophorectomy in the age range 15–30 years
48. Early menopausal changes in bone mass and sex steroids
49. 125I-17B-estradiol binding
50. Bone mineral content of the lumbar spine in normal and osteoporotic women: cross-sectional and longitudinal studies
51. Correlation between vertebral bone density measurement and nutritional status
52. Relation of physical and lifestyle factors to vertebral and femoral neck bone density in premenopausal women
53. Long-term prevention of postmenopausal osteoporosis by oestrogen
54. Prevention of spinal osteoporosis in oophorectomised women
55. Vertebral and total body bone mineral content by dual photon absorptiometry
56. Plasma androstenedione and oestrone levels in normal and osteoporotic postmenopausal women
57. Bone status and fracture rates in two regions of Yugoslavia
58. Reduced bone mineral content in totally thyroidectomized patients: possible effect of calcitonin deficiency
59. Comparison of human calcitonin secretion after a 1-minute calcium infusion in young normal and in elderly subjects
60. The effect of oestrogens on human calcitonin secretion after calcium infusion in elderly female subjects
61. Calcium supplementation and postmenopausal bone loss
62. Osteomalacia, osteoporosis and calcium deficiency
63. The effect of sex steroid and corticosteroid hormones on bone
64. Bone formation and resorption as the determinants of trabecular bone volume in postmenopausal osteoporosis
65. Estrogen receptors in bone. An evaluation of the uptake of estrogen into bone cells
66. Photon absorptiometric analysis of bone density in primary hyperparathyroidism
67. Calcitonin secretion in normal human subjects
68. Physical fitness is a major determinant of femoral neck and lumbar spine bone mineral density
69. Prostaglandins in bone and mineral metabolism
70. Role of drugs in fractures of the femoral neck
71. Psychotropic drug use and the risk of hip fracture
72. Effects of estrogens and calcium carbonate on bone loss in postmenopausal women
73. 1-year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin
74. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss
75. Evidence for two distinct syndromes of involutional osteoporosis
76. Effect of sex hormones on bone in primary osteoporosis
77. Role of hormonal factors in the pathogenesis of postmenopausal osteoporosis
78. A syndrome of osteoporosis, increased parathyroid hormone, and inappropriate low 1,25-dihydroxy-vitamin D
79. Assessment of 25-hydroxyvitamin D 1-hydroxylase reserve in postmenopausal osteoporosis by administration of parathyroid extract
80. Changes in bone mineral density of the proximal femur and spine with aging
81. Does calcium supplementation prevent postmenopausal bone loss?
82. Immunoreactive calcitonin in the mother, neonate, child and adult
83. Postmenopausal bone density and milk consumption in childhood and adolescence
84. Conversion of androstenedione to estrone by human fat tissue
85. Genetic factors in determining bone mass
86. Interrelation of oestrogen and the major calcium regulating hormones
87. Differential effects of aging and menopause on CT secretion
88. Postmenopausal osteoporosis
89. A physiological role for calcitonin: protection of the maternal skeleton
90. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens
91. Osteoporosis and calcitonin deficiency
92. Regulation of calcium-regulating hormones by exogenous sex steroids in early postmenopause
93. Racial differences in calcitonin and katacalcin
94. Osteoporosis with hip fracture: changes in calcium regulating hormones
95. Axial and peripheral CT scanning: findings in the early postmenopause
96. Regional and total skeletal measurements in the early postmenopause
97. Assessment of therapeutic options for prevention of bone loss
98. Deficient calcitonin response to calcium stimulation in post-menopausal osteoporosis
99. Does oral contraceptive therapy affect calcitonin secretion in premenopausal women?
100. Calcitonin secretion in postmenopausal osteoporosis
101. Secretion and metabolism of monomeric human calcitonin: effects of age, sex, and thyroid damage
102. Can a relative calcitonin deficiency contribute to the development of postmenopausal osteoporosis?
103. Impaired vitamin D metabolism with aging in women
104. Interrelations of calcium regulating hormones during normal pregnancy
105. Effect of castration on calcium regulating hormones
106. Prolonged effect of estradiol on calcitonin secretion
107. EFFECTS OF NATURAL AND ARTIFICIAL MENOPAUSE ON PLASMA AND URINARY CALCIUM AND PHOSPHORUS